Latest Breaking News On - Merdury biopharmaceutical corp - Page 3 : comparemela.com

Stock Market | FinancialContent Business Page

Stock Market | FinancialContent Business Page
financialcontent.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialcontent.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesT ai peiRobin yangTopmed international biotech co ltdAinos incChemical pharmaceutical co ltdMerdury biopharmaceutical corpTaipei exchange emerging stock boardExchange commissionHsien tsaiChief executive officerTah an chemicalAinos floraChief financial officerSelf test kits

Ainos Reports Fourth Quarter and Full Year 2022 Financial Results

Ainos Reports Fourth Quarter and Full Year 2022 Financial Results
pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.

Chemical pharmaceutical co ltdAinos incTopmed international biotech co ltdMerdury biopharmaceutical corpNews networkReports fourth quarterFull yearHsien tsaiChief executive officerTah an chemicalAinos floraChief financial officerSelf test kitsOperating expensesNet loss

Ainos, Inc : Ainos and Merdury Sign MoU to Explore Phase 3 Study of VELDONA Drug Candidate for Treatment of Oral Warts in HIV-Seropositive Patients

Ainos advances commercialization of its VELDONA® low-dose interferon treatment through strategic partnershipsSAN DIEGO, CA / ACCESSWIRE / March 14, 2023 / Ainos, Inc. (NASDAQ:AIMD)(NASDAQ:AIMDW) ("Ainos"

T ai peiUnited statesSan diegoDennis riedlRobin yangTaipei exchange emerging stock boardMerdury biopharmaceutical corpExchange commissionAinos incCompany formAinos inc viewStock board taipei exchangeAmarillo biosciences incHsien tsaiAino chairmanChief executive officer